These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 27048197)
1. Cost-effectiveness of FENO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial. Beerthuizen T; Voorend-van Bergen S; van den Hout WB; Vaessen-Verberne AA; Brackel HJ; Landstra AM; van den Berg NJ; de Jongste JC; Merkus PJ; Pijnenburg MW; Sont JK Thorax; 2016 Jul; 71(7):607-13. PubMed ID: 27048197 [TBL] [Abstract][Full Text] [Related]
2. Monitoring strategies in children with asthma: a randomised controlled trial. Voorend-van Bergen S; Vaessen-Verberne AA; Brackel HJ; Landstra AM; van den Berg NJ; Hop WC; de Jongste JC; Merkus PJ; Pijnenburg MW Thorax; 2015 Jun; 70(6):543-50. PubMed ID: 25825006 [TBL] [Abstract][Full Text] [Related]
3. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care. Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK; J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865 [TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in the Management of Asthma. Brooks EA; Massanari M Manag Care; 2018 Jul; 27(7):42-48. PubMed ID: 29989901 [TBL] [Abstract][Full Text] [Related]
5. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial. Pike K; Selby A; Price S; Warner J; Connett G; Legg J; Lucas JS; Peters S; Buckley H; Magier K; Foote K; Drew K; Morris R; Lancaster N; Roberts G Clin Respir J; 2013 Apr; 7(2):204-13. PubMed ID: 22747899 [TBL] [Abstract][Full Text] [Related]
6. Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2024; 24(5):1-225. PubMed ID: 39329005 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain. Sabatelli L; Seppälä U; Sastre J; Crater G J Investig Allergol Clin Immunol; 2017; 27(2):89-97. PubMed ID: 27564130 [TBL] [Abstract][Full Text] [Related]
8. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada. Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480 [TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom. Price D; Berg J; Lindgren P Allergy; 2009 Mar; 64(3):431-8. PubMed ID: 19183419 [TBL] [Abstract][Full Text] [Related]
10. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. LaForce C; Brooks E; Herje N; Dorinsky P; Rickard K Ann Allergy Asthma Immunol; 2014 Dec; 113(6):619-23. PubMed ID: 25060819 [TBL] [Abstract][Full Text] [Related]
11. Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis. Buendía JA; Guerrero Patiño D; Sánchez Caraballo JM BMC Pulm Med; 2022 Jun; 22(1):257. PubMed ID: 35765011 [TBL] [Abstract][Full Text] [Related]
12. Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial. Hashimoto S; Brinke AT; Roldaan AC; van Veen IH; Möller GM; Sont JK; Weersink EJ; van der Zee JS; Braunstahl GJ; Zwinderman AH; Sterk PJ; Bel EH Thorax; 2011 Jun; 66(6):514-20. PubMed ID: 21474498 [TBL] [Abstract][Full Text] [Related]
13. Lung function and asthma control in school-age children managed in UK primary care: a cohort study. Lo DK; Beardsmore CS; Roland D; Richardson M; Yang Y; Danvers L; Wilson A; Gaillard EA Thorax; 2020 Feb; 75(2):101-107. PubMed ID: 31666388 [TBL] [Abstract][Full Text] [Related]
14. Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment. Honkoop PJ; Loymans RJ; Termeer EH; Snoeck-Stroband JB; Bakker MJ; Assendelft WJ; Sterk PJ; Ter Riet G; Schermer TR; Sont JK BMC Pulm Med; 2011 Nov; 11():53. PubMed ID: 22114896 [TBL] [Abstract][Full Text] [Related]
16. A guided and unguided internet- and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial. Paganini S; Lin J; Kählke F; Buntrock C; Leiding D; Ebert DD; Baumeister H BMJ Open; 2019 Apr; 9(4):e023390. PubMed ID: 30967405 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of omalizumab in severe persistent asthma in Spain: a real-life perspective. Levy AN; García A Ruiz AJ; García-Agua Soler N; Sanjuan MV J Asthma; 2015 Mar; 52(2):205-10. PubMed ID: 24995661 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Internet-based self-management compared with usual care in asthma. van der Meer V; van den Hout WB; Bakker MJ; Rabe KF; Sterk PJ; Assendelft WJ; Kievit J; Sont JK; PLoS One; 2011; 6(11):e27108. PubMed ID: 22096523 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial. Greving JP; Kaasjager HA; Vernooij JW; Hovens MM; Wierdsma J; Grandjean HM; van der Graaf Y; de Wit GA; Visseren FL BMJ Open; 2015 May; 5(5):e007128. PubMed ID: 25995238 [TBL] [Abstract][Full Text] [Related]
20. [The long-term variability of FeNO in pregnant asthmatic women with controlled asthma]. Dor-Wojnarowska A; Nittner-Marszalska M; Liebhart J; Marszalska H; Pawłowicz R; Gillert M; Kazimierczak A; -Filarska MK; Panaszek B Pneumonol Alergol Pol; 2013; 81(2):114-20. PubMed ID: 23420427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]